Published in Hepatitis Weekly, November 28th, 2005
"E-cadherin is a key cell adhesion molecule implicated as a tumor suppressor, which is frequently altered in hepatocellular carcinoma, especially in HBV-related tumors."
"Here," wrote J.O. Lee and colleagues, Pusan National University, "we report that HBV X protein (HBx) represses E-cadherin expression at the transcription level."
"Based on the differential effects of HBx natural variants, we determined that Lys-130 in the transactivation domain of HBx is critical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-11-28)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.